Ausgabe 2/2018
Inhalt (8 Artikel)
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Frontline Therapy of CLL: Evolving Treatment Paradigm
Craig S. Boddy, Shuo Ma
Chronic Lymphocytic Leukemias (N Jain, Section Editor)
Prognostic Factors in the Era of Targeted Therapies in CLL
Prajwal Boddu, Alessandra Ferrajoli
Acute Lymphocytic Leukemias (K Ballen and M Keng, Section Editors)
Novel Therapies for Older Adults With Acute Lymphoblastic Leukemia
Nicholas J. Short, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi
Acute Lymphocytic Leukemias (K Ballen and M Keng, Section Editors)
Recent Developments in Adolescent and Young Adult (AYA) Acute Lymphoblastic Leukemia
Victor M. Orellana-Noia, Michael G. Douvas
Stem Cell Transplantation (R Maziarz, Section Editor)
Managing the Mental Distress of the Hematopoietic Stem Cell Transplant (HSCT) Patient: a Focus on Delirium
Joseph Bubalo
Multiple Myeloma (P Kapoor, Section Editor)
Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies
Kristen B. McCullough, Miriam A. Hobbs, Jithma P. Abeykoon, Prashant Kapoor
Health Economics (N Khera, Section Editor)
Value-Based Care in Hematopoietic Cell Transplantation and Cellular Therapy: Challenges and Opportunities
Gunjan L. Shah, Navneet Majhail, Nandita Khera, Sergio Giralt
T-Cell and Other Lymphoproliferative Malignancies (J Zain, Section Editor)
Update on the Treatment of Anaplastic Large Cell Lymphoma
Khoan Vu, Weiyun Ai